3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Aurobindo Pharma Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition Amphotericin B Liposome, AmBisome (Amphotericin B) Liposome - Visceral Leishmaniasis | Phase 1 | Completed | Aurobindo Pharma Ltd | 140 | 2018-05-02 | 2019-08-26 |
| Bioavailability Study Comparing 10 Mg Amlodipine Besylate Orally Disintegrating Tablet (ODT) And 10 Mg Amlodipine Besylate Tablets Amlodipine - reference, Amlodipine ODT - test - Healthy Volunteers | Phase 1 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 18 | 2010-05-01 | 2021-01-28 |
| Bioavailability Study Comparing 10 mg Amlodipine Besylate Orally Disintegrating Tablets (ODT) And 10 mg Amlodipine Besylate Capsules Amlodipine - reference, Amlodipine ODT - test - Healthy Volunteers | Phase 1 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 14 | 2010-03-01 | 2021-01-28 |
Amphotericin B (1) · Liposomes (1) · liposomal amphotericin B (1)
India (3) · Bangladesh (1)
Dr. Dinesh Mondal, MD (1) · Dr. Krishna Pandey, MD (1) · Dr. Sajid Mohd, MD (1) · Dr. Shyam Sundar, MD (1) · Dr. Subhra Lahiri, Ph.D (1) · Nagesh Meda, M.Pharm (1)